Clinical Trials Logo

Clinical Trial Summary

Multicenter, prospective, study designed to demonstrate the performance and safety of the Lumen Biomedical, Inc. FiberNet Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention. The primary endpoint is the rate of all stoke and death within 30 days of the procedure.


Clinical Trial Description

The purpose of this feasibility study is to demonstrate the performance and safety of the Lumen Biomedical, Inc. FiberNet® Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention. The feasibility study will involve a maximum of 50 subjects to be enrolled using the FiberNet® during clinically indicated percutaneous intervention of the carotid artery and followed through 30 days post procedure. Subject will be enrolled in up to 5 European Investigational Sites. The study is a prospective multi-center registry with sequential enrollment of qualified subjects who consent to participate and meet all entrance criteria. ;


Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00309803
Study type Interventional
Source Lumen Biomedical
Contact
Status Completed
Phase N/A
Start date March 2006

See also
  Status Clinical Trial Phase
Completed NCT00597974 - Neurological Outcome With Carotid Artery Stenting N/A
Completed NCT00318851 - Carotid Artery Stenting With Protection Registry Phase 3
Active, not recruiting NCT03133429 - Clinical Study to Evaluate the Safety and Effectiveness of MER® Stents in Carotid Revascularisation. N/A
Recruiting NCT01440036 - The Correlation Between the Enzyme Paraoxigenase 1 (PON1) to Carotid Artery Atheromatous Plaque N/A
Completed NCT00417963 - ViVEXX Carotid Revascularization Trial (VIVA) Phase 3
Completed NCT00177346 - A Randomized Trial of Carotid Artery Stenting With and Without Cerebral Protection N/A
Not yet recruiting NCT02224209 - Comparison of Staged Angioplasty and Routine Single-stage Stenting (CAS) in the Treatment of Carotid Artery Stenosis Phase 4
Recruiting NCT02006095 - Neuroimaging Correlates of Memory Decline Following Carotid Interventions N/A
Terminated NCT01236508 - Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease Phase 4
Recruiting NCT01331473 - PROximal Protection VErsus NON-Protection in Carotid Artery Stenting Phase 3
Recruiting NCT03464851 - Evaluation of a Novel Technique to Diagnose Carotid Artery Stenosis N/A
Recruiting NCT03495830 - Stratification of Patient With Carotid Disease
Terminated NCT00597545 - Effect of Raised CBF During CEA on Cognition in DM Patients N/A
Completed NCT00597883 - Neuropsychometric Outcome After Carotid Endarterectomy N/A
Not yet recruiting NCT01547039 - Platelet Reactivity and MES During CEA N/A
Recruiting NCT01718600 - Long-term Neurocognitive Sequelae of Subclinical Microembolization During Carotid Interventions N/A
Completed NCT00677963 - Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation N/A
Completed NCT02800174 - Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis N/A
Terminated NCT00335972 - The Effects of Dexmedetomidine and Remifentanil on Carotid Patients Phase 4
Completed NCT00346515 - EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting N/A